TLDR Sunshine Biopharma launches Amoxicillin in Canada as its generic portfolio expands. SBFM begins pharmacy shipments as Amoxicillin targets a $4.9 billion market. Sunshine Biopharma adds Amoxicillin while planning 12 more launches in 2026. SBFM expands its Canadian drug portfo...
Sunshine Biopharma (SBFM) Stock: Launches Amoxicillin in Canada With 12 More Drug Launches Planned for 2026
其他语言标题
- 한국어Sunshine Biopharma (SBFM) 주식: 캐나다에서 아목시실린 출시, 2026년 추가 12개 의약품 출시 예정